Cargando…
Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents
[Image: see text] In an attempt to identify small molecules for the treatment of leukemia, 12 new pyrazolines (2a–l) were synthesized efficiently. WST-1 assay was performed to examine their cytotoxic features on HL-60 human acute promyelocytic leukemia (APL), K562 human chronic myeloid leukemia (CML...
Autores principales: | Altıntop, Mehlika Dilek, Cantürk, Zerrin, Özdemir, Ahmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652261/ https://www.ncbi.nlm.nih.gov/pubmed/38024728 http://dx.doi.org/10.1021/acsomega.3c05860 |
Ejemplares similares
-
Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents
por: Karabacak, Muhammed, et al.
Publicado: (2015) -
Design, Synthesis, and Neuroprotective Effects of a Series of Pyrazolines against 6-Hydroxydopamine-Induced Oxidative Stress
por: Özdemir, Ahmet, et al.
Publicado: (2018) -
Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2018) -
Pyrazole Incorporated New Thiosemicarbazones: Design, Synthesis and Investigation of DPP-4 Inhibitory Effects
por: Sever, Belgin, et al.
Publicado: (2020) -
Design, Synthesis,
and Evaluation of a New Series
of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy
por: Erdönmez, Burak, et al.
Publicado: (2023)